Seeing Is Believing
Currently out of the existing stock ratings of Daniel Arias, 119 are a BUY (67.23%), 58 are a HOLD (32.77%).
Analyst Daniel Arias, currently employed at STIFEL, carries an average stock price target met ratio of 55.14% that have a potential upside of 16.14% achieved within 140 days.
Daniel Arias’s has documented 331 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on TMO, Thermo Fisher Scientific at 24-Apr-2025.
Analyst best performing recommendations are on WAT (WATERS).
The best stock recommendation documented was for WAT (WATERS) at 5/8/2024. The price target of $332 was fulfilled within 1 day with a profit of $8.2 (2.53%) receiving and performance score of 25.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$116
$9.72 (9.15%)
$155
6 days ago
(21-Apr-2025)
14/20 (70%)
$15.74 (15.70%)
386
Hold
$115
$8.72 (8.20%)
$145
17 days ago
(10-Apr-2025)
11/13 (84.62%)
$15.05 (15.06%)
143
Buy
$159
$52.72 (49.60%)
$136
2 months ago
(27-Feb-2025)
9/15 (60%)
$31.92 (25.12%)
112
Hold
$150
$43.72 (41.14%)
$147
4 months 14 days ago
(13-Dec-2024)
8/8 (100%)
$11.26 (8.12%)
89
Buy
$160
$53.72 (50.55%)
$155
5 months 1 days ago
(26-Nov-2024)
0/2 (0%)
$25.88 (19.30%)
Which stock is Daniel Arias is most bullish on?
Which stock is Daniel Arias is most reserved on?
What Year was the first public recommendation made by Daniel Arias?